EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, National Research's enterprise value is $864.5 Mil.
National Research's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $46.7 Mil. Therefore, National Research's EV-to-EBITDA for today is 18.50.
The historical rank and industry rank for National Research's EV-to-EBITDA or its related term are showing as below:
NRC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.04 Med: 19.15 Max: 37.76
Current: 18.5
During the past 13 years, the highest EV-to-EBITDA of National Research was 37.76. The lowest was 6.04. And the median was 19.15.
NRC's EV-to-EBITDA is ranked worse than 64.57% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.175
vs NRC: 18.50
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
National Research EV-to-EBITDA Historical Data
The historical data trend for National Research's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of National Research's EV-to-EBITDA
For the Health Information Services subindustry, National Research's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Research's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Research's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where National Research's EV-to-EBITDA falls into.
National Research's current Enterprise Value is $864.5 Mil.
National Research's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $46.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Research (NAS:NRC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
National Research's PE Ratio for today is calculated as:
National Research's share price for today is $34.80.
National Research's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.250.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of National Research's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
National Research (National Research) Business Description
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NRC has been successfully added to your 